Broncus Medical, Inc. is a privately funded healthcare company based in San Jose, CA. The Company’s mission is to deliver innovative navigation, diagnostic and therapeutic technologies designed to improve the lives of patients with lung disease through early detection and treatment. The Company holds an impressive intellectual property portfolio of ~75 patents including those issued, licensed, and pending. With commercial and clinical operations in the US, Europe and Asia, Broncus Medical continues to focus on improved clinical outcomes for patients and healthcare professionals around the world.
In 2016, Broncus Medical released Archimedes™ - Total Lung Access Platform. The Archimedes system is an intuitive next generation virtual bronchoscopic navigation system developed with years of experience and clinical feedback from previous generation technology: LungPoint® Virtual Bronchoscopic Navigation System. Archimedes integrates CT, pattern recognition software and fused fluoroscopy to provide real-time airway navigation and Bronchoscopic Trans-Parenchymal Nodule Access (BTPNA) for peripheral lesions that are not within or adjacent to the airway. The Archimedes procedure planning software, also available as a satellite planning laptop for greater versatility, combines state-of-the-art nodule, vessel and airway mapping technology with virtual pathway guidance to ensure a safe and efficient airway or BTPNA procedure. The proprietary software and design allows for the use of existing off the shelf tools during airway navigation and a simple access kit for BTPNA. As a platform, Archimedes provides clinical options never before available for access, diagnosis and treatment of lung disease.
In 2016, Broncus Medical released Archimedes™ - Total Lung Access Platform. The Archimedes system is an intuitive next generation virtual bronchoscopic navigation system developed with years of experience and clinical feedback from previous generation technology: LungPoint® Virtual Bronchoscopic Navigation System. Archimedes integrates CT, pattern recognition software and fused fluoroscopy to provide real-time airway navigation and Bronchoscopic Trans-Parenchymal Nodule Access (BTPNA) for peripheral lesions that are not within or adjacent to the airway. The Archimedes procedure planning software, also available as a satellite planning laptop for greater versatility, combines state-of-the-art nodule, vessel and airway mapping technology with virtual pathway guidance to ensure a safe and efficient airway or BTPNA procedure. The proprietary software and design allows for the use of existing off the shelf tools during airway navigation and a simple access kit for BTPNA. As a platform, Archimedes provides clinical options never before available for access, diagnosis and treatment of lung disease.
Location: United States, California, San Jose
Phone: +1 650-428-1600
Total raised: $74.5M
Investors 5
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Lake Bleu ... | lakebleu-c... |
| - | Qiming Ven... | qimingvent... |
| - | Abingworth... | abingworth... |
| - | Qiming Ven... | qimingvc.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 12.06.2018 | Series A | $15M | - |
| 29.07.2008 | - | $30M | - |
| 01.09.2006 | - | $29.5M | - |
Mentions in press and media 13
| Date | Title | Description |
| 28.11.2023 | Deals in brief: Jala Tech confirms Series A funding, Neuralink secures additional USD 43 million, multiple China and India deals, and more | Jala Tech confirms closure of Series A round Following DealStreetAsia’s report on November 27 regarding Jala Tech completing its Series A funding round, the Indonesian aquaculture tech company has released a statement today confirming the m... |
| 27.11.2023 | Deals in brief: Alchemy Foodtech, Gently, and Jala Tech secure funding, multiple China and Middle East deals, and more | Alchemy Foodtech secures strategic investment from Ting Li Development The Singaporean food tech startup has secured SGD 8 million (USD 5.98 million) in strategic funding from Ting Li Development, the investment arm of Ting Hsin Internation... |
| 09.09.2023 | Introducing BIOSTAR® cutting-edge Conventional TBNA (cTBNA) and Endobronchial ultrasound (EBUS) TBNA (EBUS-TBNA) needle: Revolutionizing Minimally Invasive Diagnostic techniques | SAN JOSE, Calif., Sept. 9, 2023 /PRNewswire/ -- In a remarkable stride towards advancing medical technology, we are thrilled to announce the launch of our groundbreaking BioStar® Transbronchial Aspiration Needle (TBNA) designed to transform... |
| 24.09.2021 | China Digest: Qiming leads $50m round for Sunyur; Broncus goes public in $215m IPO | Qiming Venture Partners has led a 320 million yuan ($49.5 million) Series B round of financing for Sunyur, while Broncus Holding Corporation, a Chinese medical device firm also backed by Qiming, has raised HK$1.671 billion ($214.7 million) ... |
| 04.11.2020 | Broncus Holding Company Closes Series C Financing | Broncus Holding Company, a Hangzhou, China-based global leader in diagnostic and therapeutic technology for lung diseases, closed a Series C round of funding. The round was led by Lake Bleu Capital, with participation from Baidu Capital, As... |
| 13.06.2018 | Term Sheet — Wednesday, June 13 | A WILD RIDE Reports surfaced yesterday that Bird is raising even more capital. This time, the electric scooter company is looking at $200 million in venture funding at a $2 billion valuation. (Yes, this comes only two weeks after media repo... |
| 12.06.2018 | Broncus Medical Closes $15M Series A Funding | Broncus Medical, Inc., a San Jose, CA-based developer of diagnostic and therapeutic technology for lung disease, closed a Series A round of $15m. Intuitive Surgical, Inc. (Nasdaq:ISRG), a global technology leader in minimally invasive robot... |
| 05.12.2008 | Broncus inhales $38M to treat lung disease, eyes IPO | Broncus Technologies, developer of devices to treat emphysema and other lung ailments, may make a second run at going public after bringing in $38 million in seventh-round funding to break even, reports VentureWire. The Mountain View, Calif... |
| 29.07.2008 | Broncus completes debt financing, plans new $30 million round | When we last talked about Broncus Technologies, it was pulling its initial public offering plans and instead trying to line up venture debt financing. It’s done that now, completing a $10 million debt financing ahead of planned $30 million ... |
| 26.06.2008 | The dry IPO market is creating demand for alternate liquidity | The second quarter, closing Monday, is expected to be the worst in recent history for initial public offerings, as the stock market continues to face stormy conditions. An estimated 44 IPOs were pulled during the year due to lousy market co... |
Show more